2023-24 Annual report
Financial highlights
Read the 2023-24 audited financial statements
Statement of operations and changes in net assets
Year ended March 31, 2024
Expenses | 2024 | 2023 |
---|---|---|
Decrease risk of people getting cancer in Canada | 2,381,154 | 2,416,749 |
Diagnose cancer faster, accurately and at an earlier stage | 4,943,768 | 5,431,755 |
Deliver high-quality care in a sustainable, world-class system | 1,415,758 | 807,326 |
Deliver supports for patients, families and caregivers | 1,902,124 | 4,448,158 |
Culturally appropriate care closer to home | 2,801,646 | 7,219,630 |
First Nations-, Inuit-, or Métis-governed research and data systems | 783,745 | 277,293 |
Transforming research into improved care | 7,727,850 | 6,925,606 |
Maximizing the impact of health system data to drive change and improving information flow among providers and patients | 4,526,999 | 3,842,604 |
Public engagement and outreach and cancer strategy program support | 6,000,931 | 6,005,258 |
32,483,975 | 37,374,379 | |
Operating expenses (Note 4)* | 11,040,412 | 10,512,236 |
43,524,387 | 47,886,615 |
Revenue | 2024 | 2023 |
---|---|---|
Government of Canada (Note 6)* | 42,537,277 | 47,854,429 |
Other revenue | 987,110 | 32,186 |
43,524,387 |
|
Excess of revenue over expenses for the year, and net assets at the end of the year | – | – |
---|
Statement of financial position
As at March 31, 2024
Assets
Current | 2024 | 2023 |
---|---|---|
Cash | 7,184,587 | 7,348,998 |
Short-term investments | 10,584,961 | 8,224,143 |
Accounts receivable | 485,822 | 539,630 |
Projects in process – advances (Note 3)* | 995,186 | 578,189 |
Prepaid expenses | 1,414,791 | 559,245 |
20,665,347 |
| |
Capital assets (Note 4)* | 1,943,325 | 1,828,928 |
|
| |
22,608,672 |
|
Liabilities and net assets
Current | 2024 | 2023 |
---|---|---|
Accounts payable and accrued liabilities | 3,661,621 | 5,718,512 |
Government remittances payable (Note 5)* | 44,463 | 106,311 |
Deferred contributions – Expenses of future periods (Note 6 (a))* | 16,644,680 | 11,072,241 |
20,350,764 |
| |
Deferred contributions – Capital assets (Note 6 (b))* | 1,601,873 | 1,405,528 |
Lease inducements (Note 7)* | 656,035 | 776,541 |
2,257,908 |
| |
22,608,672 |
| |
Net assets | – | – |
22,608,672 |
|
*Refer to the audited financial statements for full details on the note.
Statement of cash flows
Year ended March 31, 2024
Increase (decrease) in cash
Operating activities | 2024 | 2023 |
---|---|---|
Government of Canada contributions received (Note 6)* | 47,500,000 | 47,500,000 |
Other contributions received | 898,549 | 109,990 |
Interest received on short-term investments | 806,061 | 501,056 |
Interest paid to Government of Canada | (64,151) | (70,993) |
Cash paid for programs and operating expenses | (46,624,371) | (44,921,751) |
2,516,088 |
|
Investing activities | 2024 | 2023 |
---|---|---|
Purchase of short-term investments | (6,000,000) | – |
Redemption of short-term investments | 4,000,000 | – |
(2,000,000) | - |
Financing activities | 2024 | 2023 |
---|---|---|
Purchase of capital assets | (680,499) | (217,886) |
(680,499) |
|
Increase (decrease) in cash | (164,411) | 2,900,416 |
---|---|---|
Cash, beginning of year | 7,348,998 | 4,448,582 |
Cash, end of period | 7,184,587 | 7,348,998 |